[ad_1]
Norway stopped using the AstraZeneca vaccine last Thursday after three healthcare workers under the age of 50 were also hospitalized due to blood clots and low platelet counts. One of them has already passed away. All three recently received the British-Swedish vaccine.
One of our readers drew our attention to an article in Norwegian e.g. not in which the chief physician of the National Hospital in Oslo states. Pål Andre Holme says they have evidence that the rare vaccine-induced immune response caused the severe disease in all three patients.
His colleagues had been investigating the patients’ values for days, assuming that an unexpected and extremely severe immune response had developed after administration of the vaccine. A joint study with researchers from the University of Northern Norway found that
Their bodies began to produce special antibodies against platelets after the vaccine was given, leading to a low platelet count and an increasingly serious condition.
Holme added that this rare type of immune response has been seen during other therapies, but was later triggered by medications.
Based on the medical history of the patients, the doctor states that this type of immune response could only be triggered by the vaccine. After hospitalization, all three experienced the same symptoms:
- acute pain indicated;
- blood clots formed in unusual places in their brains and stomachs;
- they experienced bleeding and low platelet counts.
In Norway, about 120,000 people have been vaccinated with the AstraZeneca vaccine so far, and in some cases only blood clots and low platelet counts have been experienced.
The Norwegian Medicines Authority has not yet commented on the test result.
After discontinuing vaccination with AstraZeneca vaccines in several European countries, the WHO and the European Medicines Agency (EMA) also began to investigate. The WHO published its position on Wednesday that the vaccination campaign could continue with the AZ vaccine. The EMA will meet on Thursday on the issue.
AstraZeneca vaccines are being administered without problems in Belgium, Hungary and several other European countries.
(Cover image: Yves Herman / Reuters)
[ad_2]
